PUMAi
PUMAi is a PUMA inhibitor that disrupts the interaction between PUMA and BCL-xL. PUMAi inhibits apoptosis, caspase-3 activation, WNT/NOTCH pathway activation, and DNA damage. PUMAi protects intestinal tissues in mice, promotes the growth of colonoids, and reduces chemotherapy-induced weight loss, gastrointestinal damage, and lethality. PUMAi alleviates acetaminophen-induced liver injury and cytoplasmic translocation of HMGB1 in mice. PUMAi can be used in studies related to gastrointestinal injury, intestinal injury, and liver injury.
For research use only. We do not sell to patients.
- CAS No.: 470695-03-5
- Formula: C19H28Cl2N2O3
- Molecular Weight:403.34
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Caspase Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
Caspase 3 |
Bcl-xL |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
PUMAi (10 mg/kg; i.p.; 2 hours before each of 3 CPT-11 doses, plus 1 dose 20 hours after final CPT-11 dose) increases survival to 70% in mice with CPT-11-induced lethal gastrointestinal injury[1].
PUMAi (10 mg/kg; i.p.; 30 minutes before irradiation, 30 minutes after irradiation, and daily for 4 subsequent days) improves survival in mice with radiation-induced gastrointestinal injury[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 470695-03-5
-
Molecular Weight 403.34
-
Formula C19H28Cl2N2O3
-
SMILES
OCCN1CCN(CC(COC2=CC3=C(C=CC=C3)C=C2)O)CC1.Cl.Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)